JP2019518030A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019518030A5 JP2019518030A5 JP2018564732A JP2018564732A JP2019518030A5 JP 2019518030 A5 JP2019518030 A5 JP 2019518030A5 JP 2018564732 A JP2018564732 A JP 2018564732A JP 2018564732 A JP2018564732 A JP 2018564732A JP 2019518030 A5 JP2019518030 A5 JP 2019518030A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- calcification
- treatment
- prevention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1610400.2 | 2016-06-15 | ||
| GBGB1610400.2A GB201610400D0 (en) | 2016-06-15 | 2016-06-15 | Vascular calcification |
| PCT/GB2017/051744 WO2017216563A1 (en) | 2016-06-15 | 2017-06-15 | Treatment of vascular calcification |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019518030A JP2019518030A (ja) | 2019-06-27 |
| JP2019518030A5 true JP2019518030A5 (enExample) | 2020-07-27 |
| JP6992952B2 JP6992952B2 (ja) | 2022-02-03 |
Family
ID=56894903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018564732A Active JP6992952B2 (ja) | 2016-06-15 | 2017-06-15 | 血管石灰化の治療 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10159685B2 (enExample) |
| EP (1) | EP3471721B1 (enExample) |
| JP (1) | JP6992952B2 (enExample) |
| CN (1) | CN109475533B (enExample) |
| CA (1) | CA3027469C (enExample) |
| ES (1) | ES2894844T3 (enExample) |
| GB (1) | GB201610400D0 (enExample) |
| WO (1) | WO2017216563A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201610400D0 (en) | 2016-06-15 | 2016-07-27 | Cambridge Entpr Ltd And Kings College London | Vascular calcification |
| US20220079899A1 (en) * | 2019-01-14 | 2022-03-17 | The Regents Of The University Of California | Compositions and methods for treating ocular conditions |
| CN113940935A (zh) * | 2021-10-09 | 2022-01-18 | 华中科技大学同济医学院附属协和医院 | 奥拉帕尼的新用途 |
| CN114010635A (zh) * | 2021-11-21 | 2022-02-08 | 华中科技大学同济医学院附属协和医院 | 尼拉帕尼及其衍生物的新用途 |
| CN120392751A (zh) * | 2025-07-04 | 2025-08-01 | 吉林大学 | Parp1抑制剂在制备防治放射性肺损伤药物中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6514983B1 (en) | 1997-09-03 | 2003-02-04 | Guilford Pharmaceuticals Inc. | Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| US6706290B1 (en) | 1998-07-06 | 2004-03-16 | Olvai E. Kajander | Methods for eradication of nanobacteria |
| ATE282959T1 (de) | 1998-07-06 | 2004-12-15 | Nanobac Oy | Verfahren zur beseitigung von nanobakterien |
| WO2005020926A2 (en) * | 2003-08-28 | 2005-03-10 | Pharmacia Corporation | Treatment or prevention of vascular disorders with cox-2 inhibitors in combination with cyclic amp-specific phosphodiesterase inhibitors |
| JP2007535502A (ja) | 2004-03-12 | 2007-12-06 | コッラジェネックス ファーマシューチカルス インコーポレイテッド | 非抗菌性テトラサイクリン製剤による大動脈弁狭窄症の治療方法 |
| US20060069068A1 (en) | 2004-07-15 | 2006-03-30 | Nanobac Pharmaceuticals, Inc. | Methods and compositions for the treatment of diseases characterized by pathological calcification |
| US20060083727A1 (en) | 2004-07-15 | 2006-04-20 | Nanobac Pharmaceuticals, Inc. | Methods and compositions for the treatment of diseases characterized by calcification and/or plaque formation |
| US20100292183A1 (en) | 2009-05-15 | 2010-11-18 | Shanmugavel Madasamy | Tetracycline and uses thereof |
| GB201020811D0 (en) | 2010-12-08 | 2011-01-19 | Solvotrin Innovations Ltd | Compounds |
| US9314473B2 (en) | 2011-02-03 | 2016-04-19 | Pop Test Oncology Limited Liability Company | System and method for diagnosis and treatment |
| EP2709618A4 (en) | 2011-05-10 | 2014-11-05 | UNIVERSITé LAVAL | METHOD FOR THE TREATMENT AND DIAGNOSIS OF PULMONARY ARTERIAL HYPERTENSION |
| WO2016051213A1 (en) | 2014-12-17 | 2016-04-07 | Clinigen Group Plc | Par inhibition |
| GB201610400D0 (en) | 2016-06-15 | 2016-07-27 | Cambridge Entpr Ltd And Kings College London | Vascular calcification |
-
2016
- 2016-06-15 GB GBGB1610400.2A patent/GB201610400D0/en not_active Ceased
-
2017
- 2017-06-15 CA CA3027469A patent/CA3027469C/en active Active
- 2017-06-15 US US15/624,299 patent/US10159685B2/en active Active
- 2017-06-15 JP JP2018564732A patent/JP6992952B2/ja active Active
- 2017-06-15 ES ES17732176T patent/ES2894844T3/es active Active
- 2017-06-15 EP EP17732176.7A patent/EP3471721B1/en active Active
- 2017-06-15 WO PCT/GB2017/051744 patent/WO2017216563A1/en not_active Ceased
- 2017-06-15 CN CN201780037445.9A patent/CN109475533B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019518030A5 (enExample) | ||
| ES2912373T3 (es) | Tratamiento de un paciente con un fármaco sustrato de CYP3A4 contraindicado para la administración concomitante con un inhibidor potente de CYP3A4 | |
| CN101686972B (zh) | 治疗用组合物和方法 | |
| JP2015512406A5 (enExample) | ||
| JP2015515475A5 (enExample) | ||
| RU2017134443A (ru) | Способ лечения с применением традипитанта | |
| JP2006508953A5 (enExample) | ||
| CN111902417A (zh) | 一种二芳基巨环化合物、药物组合物以及其用途 | |
| HK1206937A1 (en) | Methods of administering pirfenidone therapy | |
| JP2012512158A5 (enExample) | ||
| JP2009541348A5 (enExample) | ||
| JP2018529742A5 (enExample) | ||
| HK1206246A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| JP2005511749A (ja) | Ｂ型肝炎ウィルス感染症を治療するためのホスホネートヌクレオチド類似体の使用 | |
| JP2014525454A5 (enExample) | ||
| JP2013515690A (ja) | アルテミシニンベースの薬剤と他の化学療法薬の抗癌用組合せ | |
| JP2023065622A (ja) | 重度腎機能障害を有する癌患者に対する治療方法 | |
| JP2016094450A5 (enExample) | ||
| JP2009525265A5 (enExample) | ||
| JP2015522077A5 (enExample) | ||
| JPWO2013089164A1 (ja) | 高度腎機能障害を有する血栓塞栓症患者の血栓塞栓症の予防治療剤 | |
| PH12019500516A1 (en) | Pharmaceutical composition comprising mineralocorticoid receptor antagonist and use thereof | |
| JP2018506533A5 (enExample) | ||
| CN117940125A (zh) | His弱应答者的治疗 | |
| CN105358148A (zh) | 用于治疗肾小球疾病的losmapimod |